Literature DB >> 3141926

Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells.

D Harding1, S Fournel-Gigleux, M R Jackson, B Burchell.   

Abstract

A rat kidney phenol UDP-glucuronosyltransferase cDNA was used to isolate a human liver phenol UDP-glucuronosyltransferase cDNA by screening of a human liver cDNA library in the expression vector lambda gt11. The 2.4-kilobase cDNA contained an open reading frame of 1593 base pairs coding for a protein of 531 residues. The human liver cDNA was subcloned into the vector pKCRH2. Transfection of this recombinant plasmid into COS-7 cells allowed the expression of a protein of approximately 55 kDa. The enzyme synthesized was a glycoprotein, as indicated by a reduction in molecular mass of approximately 3 kDa after biosynthesis in the presence of tunicamycin. The expressed enzyme rapidly catalyzed the glucuronidation of 1-naphthol, 4-methylumbelliferone, and 4-nitrophenol. The use of a related series of simple phenols provided an outline description of the substituent restrictions imposed upon the phenolic structures accepted as substrates. The glucuronidation of testosterone, androsterone, and estrone was not catalyzed by this cloned UDP-glucuronosyltransferase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141926      PMCID: PMC282461          DOI: 10.1073/pnas.85.22.8381

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

Review 2.  Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity.

Authors:  I M Arias; L M Gartner; M Cohen; J B Ezzer; A J Levi
Journal:  Am J Med       Date:  1969-09       Impact factor: 4.965

3.  UDP-glucuronyltransferase in perfused rat liver and in microsomes - III. Effects of galactosamine and carbon tetrachloride on the glucuronidation of 1-naphthol and bilirubin.

Authors:  G Otani; M M Abou-El-Makarem; K W Bock
Journal:  Biochem Pharmacol       Date:  1976-06-01       Impact factor: 5.858

4.  Determination of microsomal UDP-glucuronyltransferase in needle-biopsy specimens of human liver.

Authors:  K W Bock; G Brunner; H Hoensch; E Huber; D Josting
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

5.  Demonstration of two functionally heterogenous groups within the activities of UDP-glucuronosyltransferase towards a series of 4-alkyl-substituted phenols.

Authors:  G J Wishart; M T Campbell
Journal:  Biochem J       Date:  1979-02-15       Impact factor: 3.857

6.  Regulation of simian virus 40 transcription: sensitive analysis of the RNA species present early in infections by virus or viral DNA.

Authors:  B A Parker; G R Stark
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

7.  Purification and specificity of a human microsomal epoxide hydratase.

Authors:  F Oesch
Journal:  Biochem J       Date:  1974-04       Impact factor: 3.857

8.  A system for shotgun DNA sequencing.

Authors:  J Messing; R Crea; P H Seeburg
Journal:  Nucleic Acids Res       Date:  1981-01-24       Impact factor: 16.971

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphthol glucuronidation in human liver microsomes.

Authors:  J O Miners; K J Lillywhite; A P Matthews; M E Jones; D J Birkett
Journal:  Biochem Pharmacol       Date:  1988-02-15       Impact factor: 5.858

View more
  16 in total

Review 1.  Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

2.  The novel UGT1 gene complex links bilirubin, xenobiotics, and therapeutic drug metabolism by encoding UDP-glucuronosyltransferase isozymes with a common carboxyl terminus.

Authors:  I S Owens; J K Ritter; M T Yeatman; F Chen
Journal:  J Pharmacokinet Biopharm       Date:  1996-10

3.  Cloning and stable expression of a new member of the human liver phenol/bilirubin: UDP-glucuronosyltransferase cDNA family.

Authors:  R Wooster; L Sutherland; T Ebner; D Clarke; O Da Cruz e Silva; B Burchell
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

4.  Immunochemical analysis of uridine diphosphate-glucuronosyltransferase in four patients with the Crigler-Najjar syndrome type I.

Authors:  H H van Es; B G Goldhoorn; M Paul-Abrahamse; R P Elferink; P L Jansen
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

5.  Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.

Authors:  L Iyer; C D King; P F Whitington; M D Green; S K Roy; T R Tephly; B L Coffman; M J Ratain
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

6.  Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient.

Authors:  J K Ritter; M T Yeatman; P Ferreira; I S Owens
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

7.  Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.

Authors:  C P Strassburg; A Strassburg; N Nguyen; Q Li; M P Manns; R H Tukey
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

8.  Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implication in carrier detection and prenatal diagnosis.

Authors:  N Moghrabi; D J Clarke; B Burchell; M Boxer
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

Review 9.  Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.

Authors:  H K Kroemer; U Klotz
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

10.  mtDNA depletion confers specific gene expression profiles in human cells grown in culture and in xenograft.

Authors:  Darren Magda; Philip Lecane; Julia Prescott; Patricia Thiemann; Xuan Ma; Patricia K Dranchak; Donna M Toleno; Krishna Ramaswamy; Kimberly D Siegmund; Joseph G Hacia
Journal:  BMC Genomics       Date:  2008-11-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.